We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$1.5B
(-8.1%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-19.02%
Top 10 Holdings %
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coeur Mining
CDE
|
+$20.8M |
| 2 |
Atlantic Union Bankshares
AUB
|
+$16.7M |
| 3 |
Lincoln National
LNC
|
+$14.7M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$13.3M |
| 5 |
Yeti Holdings
YETI
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$997M |
| 2 |
Amazon
AMZN
|
+$539M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$276M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 5 |
Bank of America
BAC
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.35% |
| 2 | Financials | 13.45% |
| 3 | Industrials | 10.46% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
2626
DELISTED
Sleep Number
SNBR
| $82.2K | ﹤0.01% |
12,173
+2,832
| +30% | +$21.6K |
|
2627
RE/MAX Holdings
RMAX
$263M
| $82.2K | ﹤0.01% |
10,051
+3,078
| +44% | +$23.9K |
|
|
STLN
2628
Starling Oncology, Inc. Common Stock
STLN
$644M
| $81.9K | ﹤0.01% |
+39,945
| New | +$99.9K |
|
|
BFIN
2629
DELISTED
BankFinancial
BFIN
| $81.3K | ﹤0.01% |
+7,023
| New | +$83.8K |
|
|
SCPH
2630
DELISTED
scPharmaceuticals
SCPH
| $81.3K | ﹤0.01% |
+21,326
| New | +$66.2K |
|
|
NB
2631
NioCorp Developments
NB
$760M
| $81.2K | ﹤0.01% |
+34,862
| New | +$87K |
|
|
CCC
2632
CCC Intelligent Solutions
CCC
$4.11B
| $81.2K | ﹤0.01% |
8,625
-36
| -0.4% | -$322 |
|
2633
Aclaris Therapeutics
ACRS
$860M
| $80K | ﹤0.01% |
+56,344
| New | +$76.2K |
|
2634
BK Technologies
BKTI
$292M
| $79.8K | ﹤0.01% |
+1,693
| New | +$75.7K |
|
2635
Avita Medical
RCEL
$251M
| $79.7K | ﹤0.01% |
15,059
| – | – |
|
2636
American Outdoor Brands
AOUT
$159M
| $79.6K | ﹤0.01% |
+7,620
| New | +$87.2K |
|
2637
Birkenstock
BIRK
$6.76B
| $79.2K | ﹤0.01% |
1,611
+905
| +128% | +$46.5K |
|
2638
DoubleVerify
DV
$2.04B
| $78.3K | ﹤0.01% |
5,230
-840
| -14% | -$11.5K |
|
2639
Trump Media & Technology Group
DJT
$2.3B
| $77.3K | ﹤0.01% |
4,285
+635
| +17% | +$13.8K |
|
2640
KRONOS Worldwide
KRO
$905M
| $76.3K | ﹤0.01% |
12,314
| – | – |
|
2641
Larimar Therapeutics
LRMR
$454M
| $76.2K | ﹤0.01% |
+26,359
| New | +$61K |
|
2642
Fate Therapeutics
FATE
$317M
| $76.1K | ﹤0.01% |
+67,990
| New | +$79K |
|
2643
Stereotaxis
STXS
$139M
| $75.9K | ﹤0.01% |
+35,795
| New | +$72.7K |
|
2644
SoundThinking
SSTI
$106M
| $75.8K | ﹤0.01% |
5,808
| – | – |
|
2645
White Mountains Insurance
WTM
$5.06B
| $75.4K | ﹤0.01% |
42
-3
| -7% | -$5.34K |
|
2646
Credit Acceptance
CACC
$5.99B
| $75.4K | ﹤0.01% |
148
-177
| -54% | -$87K |
|
|
SEE
2647
DELISTED
Sealed Air
SEE
| $75.4K | ﹤0.01% |
2,429
-528
| -18% | -$15.7K |
|
2648
Brookfield Renewable
BEPC
$6.5B
| $73.7K | ﹤0.01% |
2,249
-215
| -9% | -$6.28K |
|
2649
SiriusXM
SIRI
$9.59B
| $72.6K | ﹤0.01% |
3,162
-706
| -18% | -$15.2K |
|
2650
CPI Card Group
PMTS
$341M
| $72.4K | ﹤0.01% |
3,051
| – | – |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.
- MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
- MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
- MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
- MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
- MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
- MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
- MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.
Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.